Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy
Clinical trial NCT02858908 · COMPLETED
Trial details
- NCT number
- NCT02858908
- Sponsor
- AMO Pharma Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-20
- Primary completion
- 2018-01-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.